Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT03906539
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 150 participants
- Registry
-
NCT03906539
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT03906539. Randomized; double masking; primary purpose treatment. Start 2019-05-22 (actual); primary completion 2021-11-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia
- Condition
- Dyslipidemias
- Intervention (Drug)
- Atorvastatin 10mg
- Intervention (Dietary supplement)
- Virgin Coconut Oil (VCO)
- Intervention (Other)
- Placebo
- Lead sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Collaborator
- Coconut Development Board, Government of India
Record details
- Record id
cardio:ct-nct03906539- Content hash
96524e73a2a8faba6ef4adf215b2438fa8db40d71950461c7c7e6cafa589e34c